Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |